Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of Continuous Hemodialysis With an Enhanced Middle Molecule Clearance Membrane in Intensive Care

NCT01067313 is registered in ClinicalTrials.gov with Fresenius Medical Care France as lead sponsor.

NCT NCT01067313
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01067313 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of Continuous Hemodialysis With an Enhanced Middle Molecule Clearance Membrane in Intensive Care
Lead sponsor
Fresenius Medical Care France
Phase
Phase 2/3
Overall status
Completed
Start date
July 31, 2008
Completion date
January 31, 2011
Enrollment
24 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock